Quote | Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)
Last: | $8.14 |
---|---|
Change Percent: | -1.45% |
Open: | $7.72 |
Close: | $8.14 |
High: | $8.19 |
Low: | $7.5 |
Volume: | 4,147,472 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)
2024-07-13 09:29:00 ET Recursion Pharmaceuticals (NASDAQ: RXRX) is arguably one of the most unique drugmakers on the planet. Though it's classified as a biotech company, its claim to fame is an artificial intelligence (AI)-based approach to speeding up drug discovery and development...
2024-07-11 10:10:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at transformative innovation in biopharma, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmac...
Message Board Posts | Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)
Subject | By | Source | When |
---|---|---|---|
$RXRX: My new system works!!! (God BLESS my ASK!!!!) | Invest-in-America | investorshub | 07/12/2023 4:16:55 PM |
Okay wow! | Frankestin | investorshub | 07/12/2023 1:30:19 PM |
no 1 on the Barchart Top 100 | Monksdream | investorshub | 07/12/2023 1:18:58 PM |
Bezinga!!!!!! Recursion Announces Collaboration and $50 Million Investment fr | TheFinalCD | investorshub | 07/12/2023 1:04:24 PM |
Yup right again $RXRX | Triple nickle | investorshub | 07/12/2023 12:38:23 PM |
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
Recursion Pharmaceuticals Inc. Website:
2024-07-13 09:29:00 ET Recursion Pharmaceuticals (NASDAQ: RXRX) is arguably one of the most unique drugmakers on the planet. Though it's classified as a biotech company, its claim to fame is an artificial intelligence (AI)-based approach to speeding up drug discovery and development...
2024-07-11 10:10:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at transformative innovation in biopharma, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmac...